Review of current issues of diagnosis and prevention of blood-borne nosocomial viral infections

Cover Page


Cite item

Full Text

Abstract

Provision of infection security in transplantology and transfusiology is a challenging and significant problem that depends on the quality of medical donor selection and laboratory diagnosis of the blood collected. At present, a large number of blood-borne viruses are known; nevertheless, in Russia, the list of viral agents to be tested during the examination by the blood service boils down to three ones: HIV, hepatitis C and hepatitis B viruses.
The review article demonstrates the need for implementation of additional laboratory tests for the agents of the priority healthcare-associated blood-borne infections (HAI) using a risk-based approach, i.e., on specified sites and in high risk groups. It presents a methodology for determination of a quantitative blood-induced infection residual risk (BIRR) index to be used while evaluating the efficiency of viral security provision in the blood service.

About the authors

V. G. Akimkin

Central Institute of Epidemiology

Email: fake@neicon.ru
ORCID iD: 0000-0003-4228-9044
Moscow, 111123 Россия

A. V. Alimov

Yekaterinburg Research Institute of Viral Infections

Email: fake@neicon.ru
ORCID iD: 0000-0003-0511-9409
Yekaterinburg, 620030

Россия

Yu. A. Zakharova

Yekaterinburg Research Institute of Viral Infections

Author for correspondence.
Email: z.y.alexandrovna@mail.ru
ORCID iD: 0000-0003-3416-0902

Holder of postdoctoral degree in Medicine, Deputy Director for
Science

Yekaterinburg, 620030, 23 Letnya str., Russia

Россия

E. V. Bolgarova

Yekaterinburg Research Institute of Viral Infections

Email: fake@neicon.ru
ORCID iD: 0000-0001-6140-2546
Yekaterinburg, 620030

Россия

M. V. Piterskiy

Yekaterinburg Research Institute of Viral Infections

Email: fake@neicon.ru
ORCID iD: 0000-0001-5506-2389
Yekaterinburg, 620030

Россия

E. I. Sisin

Yekaterinburg Research Institute of Viral Infections

Email: fake@neicon.ru
ORCID iD: 0000-0001-5003-1110
Yekaterinburg, 620030

Россия

References

  1. Moustafa A., Xie C., Kirkness E., Biggs W., Wong E., Turpaz Y., et al. The blood DNA virome in 8,000 humans. PLoS Pathog. 2017; 13(3): e1006292. Doi: https://doi.org/10.1371/journal.ppat.1006292
  2. Smith D.B., Becher P., Bukh J., Gould E.A., Meyers G., Monath T., et al. Proposed update to the taxonomy of the genera Hepacivirus and Pegivirus within the Flaviviridae family. J. Gen. Virol. 2016; 97(11): 2894-907. Doi: https://doi.org/10.1099/jgv.0.000612
  3. Stapleton J.T., Foung S., Muerhoff A.S., Bukh J., Simmonds P. The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae. J. Gen. Virol. 2011; 92 (Pt. 2): 233-46. Doi: https://doi.org/10.1099/vir.0.027490-0
  4. Genus: Pegivirus – Flaviviridae – Positive sense RNA viruses. International Committee on Taxonomy of Viruses. Available at: http://talk.ictvonline.org/ictv-reports/ictv_online_report/positivesense-rna-viruses/w/flaviviridae/363/genus-pegivirus/
  5. Berg M.G., Lee D., Coller K., Frankel M., Aronsohn A., Cheng K., et al. Discovery of a novel human Pegivirus in blood associated with Hepatitis C virus co-Infection. PLoS Pathog. 2015; 11(12): e1005325. Doi: https://doi.org/10.1371/journal.ppat.1005325
  6. Pisani G., Cristiano K., Pupella S., Liumbruno G.M. West Nile virus in Europe and safety of blood transfusion. Transfus. Med. Hemother. 2016; 43(3): 158-67. Doi: https://doi.org/10.1159/000446219
  7. Goodnough L.T., Marques M.B. Zika virus and patient blood management. Anesth. Analg. 2017; 124(1): 282-9. Doi: https://doi.org/10.1213/ANE.0000000000001770
  8. Marano G., Pupella S., Vaglio S., Liumbruno G.M., Grazzini G. Zika virus and the never-ending story of emerging pathogens and transfusion medicine. Blood Transfus. 2016; 14(2): 95-100. Doi: https://doi.org/10.2450/2015.0066-15
  9. Pozzetto B., Memmi M., Garraud O. Is transfusion-transmitted dengue fever a potential public health threat? World J. Virol. 2015; 4(2): 113-23. Doi: https://doi.org/10.5501/wjv.v4.i2.113
  10. Domanovic D., Tedder R., Blümel J., Zaaijer H., Gallian P., Niederhauser C., et al. Hepatitis E and blood donation safety in selected European countries: a shift to screening? Euro Surveill. 2017; 22(16): pii: 30514. Doi: https://doi.org/10.2807/1560-7917.ES.2017.22.16.30514
  11. Nishizawa T., Okamoto H., Konishi K., Yoshizawa H., Miyakawa Y., Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem. Biophys. Res. Commun. 1997; 241(1): 92-7. Doi: https://doi.org/10.1006/bbrc.1997.7765
  12. Poovorawan Y., Tangkijvanich P., Theamboonlers A., Hirsch P. Transfusion transmissible virus TTV and its putative role in the etiology of liver disease. Hepatogastroenterology. 2001; 48(37): 256-60.
  13. Ali S., Fevery J., Peerlinck K., Verslype C., Schelstraete R., Gyselinck F., et al. TTV infection and its relation to serum transaminases in apparently healthy blood donors and in patients with clotting disorders who have been investigated previously for hepatitis C virus and GBV-C/HGV infection in Belgium. J. Med. Virol. 2002; 66(4): 561-6.
  14. Parvoviridae – ssDNA viruses (2011) – ssDNA viruses (2011). International Committee on Taxonomy of Viruses. Available at: http://talk.ictvonline.org/ictv-reports/ictv_9th_report/ssdna-viruses-2011/w/ssdna_viruses/151/parvoviridae/
  15. Nagaharu K., Sugimoto Y., Hoshi Y., Yamaguchi T., Ito R., Matsubayashi K., et al. Persistent symptomatic parvovirus B19 infection with severe thrombocytopenia transmitted by red blood cell transfusion containing low parvovirus B19 DNA levels. Transfusion. 2017; 57(6): 1414-8. Doi: https://doi.org/10.1111/trf.14088
  16. Jones M.S., Kapoor A., Lukashov V.V., Simmonds P., Hecht F., Delwart E. New DNA viruses identified in patients with acute viral infection syndrome. J. Virol. 2005; 79(13): 8230-6. Doi: https://doi.org/10.1128/JVI.79.13.8230-8236.2005
  17. Sharp C.P., Lail A., Donfield S., Gomperts E.D., Simmonds P. Virologic and clinical features of primary infection with human parvovirus 4 in subjects with hemophilia: frequent transmission by virally inactivated clotting factor concentrates. Transfusion. 2012; 52(7): 1482-9. Doi: https://doi.org/10.1111 / j.1537-2995.2011.03420.x
  18. Anelloviridae – ssDNA viruses (2011) – ssDNA viruses (2011). International Committee on Taxonomy of Viruses. Available at: http://talk.ictvonline.org/ictv-reports/ictv_9th_report/ssdna-viruses-2011/w/ssdna_viruses/139/anelloviridae/
  19. Soldan K., Davison K. How to assess risk: prospective studies and calculations. In: Barbara J.A.J., Regan F.A.M., Contreras M.C., eds. Transfusion Microbiology. Cambridge: Cambridge University Press; 2008: 330-40.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2019 Akimkin V.G., Alimov A.V., Zakharova Y.A., Bolgarova E.V., Piterskiy M.V., Sisin E.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-77676 от 29.01.2020.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies